Efficacy and Safety of Dalbavancin As Suppressive Therapy
Efficacy and Safety of Dalbavancin As Suppressive Therapy
Recruiting · NCT06899906 · Registry updated 2025-03-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Dalbavancin As Suppressive Therapy | Efficacy and Safety of Dalbavancin; For Acute or Chronic Infections Between July 2019 and December 2024; In Subjects Who Received SAT with DAL | Recruiting | Not stated | 2025-03-28 | NCT06899906 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Hospices Civils de Lyon | 429 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| HCL | France | France | 1 |